Showing Results for
- Academic Journals (359)
Search Results
- 359
Academic Journals
- 359
-
From:PLoS ONE (Vol. 16, Issue 12) Peer-ReviewedIn-depth study of the entire SARS-CoV-2 genome has uncovered many mutations, which have replaced the lineage that characterized the first wave of infections all around the world. In December 2020, the outbreak of variant...
-
From:PLoS ONE (Vol. 16, Issue 5) Peer-ReviewedBackground The first US case of SARS-CoV-2 infection was detected on January 20, 2020. However, some serology studies suggest SARS-CoV-2 may have been present in the United States prior to that, as early as December...
-
From:Emerging Infectious Diseases (Vol. 27, Issue 3) Peer-ReviewedIn December 2020, research surveillance detected the B.1.1.7 lineage of severe acute respiratory syndrome coronavirus 2 in Sao Paulo, Brazil. Rapid genomic sequencing and phylogenetic analysis revealed 2 distinct...
-
From:Nature (Vol. 593, Issue 7859) Peer-ReviewedThe COVID-19 pandemic is the third outbreak this century of a zoonotic disease caused by a coronavirus, following the emergence of severe acute respiratory syndrome (SARS) in 2003.sup.1 and Middle East respiratory...
-
From:Nature Biotechnology (Vol. 39, Issue 5) Peer-ReviewedTo keep ahead of an increasing number of SARS-CoV-2 variants, pathogen surveillance and testing must become a joined-up global, rather than local, endeavor. Author Affiliations: An arms race is underway between...
-
From:Nature (Vol. 578, Issue 7794) Peer-ReviewedThe latest science news, in brief. The latest science news, in brief. Author Affiliations: CRISPR enhancement, coronavirus source and a controversial appointment Pangolins are scaly creatures often used in...
-
From:Nature (Vol. 593, Issue 7859) Peer-ReviewedData from Qatar provide strongest evidence yet that COVID-19 vaccines can stop strains thought to pose a threat to immunization efforts. Data from Qatar provide strongest evidence yet that COVID-19 vaccines can stop...
-
From:CMAJ: Canadian Medical Association Journal (Vol. 193, Issue 28) Peer-ReviewedThe World Health Organization recently announced a new naming system for SARS-CoV-2 variants using the Greek alphabet. The new naming system is aimed at preventing people from referring to the variants by the country...
-
From:PLoS ONE (Vol. 16, Issue 8) Peer-ReviewedIntroduction Recently, several single center studies have suggested a protective effect of the influenza vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This study utilizes a continuously...
-
From:PLoS ONE (Vol. 17, Issue 1) Peer-ReviewedThe highly contagious nature of SARS-CoV-2 has led to several studies on the transmission of the virus. A little studied potential fomite of great concern in the community is currency, which has been shown to harbor...
-
From:PLoS ONE (Vol. 17, Issue 5) Peer-ReviewedEstimating the basic reproduction number of a pandemic and the changes that appear on this value over time provide a good understanding of the contagious nature of the virus and efficiency of the controlling strategies....
-
From:PLoS ONE (Vol. 17, Issue 7) Peer-ReviewedThe last year of Covid-19 pandemic has been characterized by the continuous chase between the vaccination campaign and the appearance of new variants that puts further obstacles to the possibility of eradicating the...
-
From:Emerging Infectious Diseases (Vol. 28, Issue 4) Peer-ReviewedLimited genomic sampling in many high-incidence countries has impeded studies of severe respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic epidemiology. Consequently, critical questions remain about the generation...
-
From:Emerging Infectious Diseases (Vol. 28, Issue 6) Peer-ReviewedWe studied SARS-CoV-2 genomes from travelers arriving in Hong Kong during November 2021-February 2022. In addition to Omicron and Delta variants, we detected a BA.1/BA.2 recombinant with a breakpoint near the 5' end of...
-
From:CMAJ: Canadian Medical Association Journal (Vol. 194, Issue 18) Peer-ReviewedCanada recently reported its first cases of the Omicron subvariant XE, one of several hybrid variants of SARS-CoV-2 that have emerged since the beginning of this year. First detected in the United Kingdom in January,...
-
From:Emerging Infectious Diseases (Vol. 28, Issue 3) Peer-ReviewedThe emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in late 2020 and early 2021 raised alarm worldwide because of their potential for increased transmissibility and immune...
-
From:Emerging Infectious Diseases (Vol. 28, Issue 11) Peer-ReviewedA SARS-CoV-2 P.1 (Gamma) variant outbreak occurred at a skilled nursing facility in Washington, USA, in April 2021. Effectiveness of 2 doses of mRNA vaccines against P.1 infection among residents in this outbreak was...
-
From:CMAJ: Canadian Medical Association Journal (Vol. 193, Issue 42) Peer-ReviewedNew research shows that SARS-CoV-2 variants of concern (VOCs) are more virulent than the native strain, in addition to being more transmissible. (1) Fisman and Tuite used Ontario's COVID-19 case data to estimate the...
-
From:Emerging Infectious Diseases (Vol. 29, Issue 4) Peer-ReviewedWe reconstructed the SARS-CoV-2 epidemic caused by Omicron variant in Puerto Rico by sampling genomes collected during October 2021-May 2022. Our study revealed that Omicron BA.1 emerged and replaced Delta as the...
-
From:PLoS ONE (Vol. 18, Issue 3) Peer-ReviewedThe active global SARS-CoV-2 pandemic caused more than 426 million cases and 5.8 million deaths worldwide. The development of completely new drugs for such a novel disease is a challenging, time intensive process....